Axillary De-Escalation After Neoadjuvant Therapy in cN2/N3 HER2-Positive and Triple-Negative Breast Cancer: Navigating Biological Promise and Clinical Uncertainty.
- DOI
- 10.3390/cancers18182986
- Published
- 2026 Sep 15
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18182986,
title = {Axillary De-Escalation After Neoadjuvant Therapy in cN2/N3 HER2-Positive and Triple-Negative Breast Cancer: Navigating Biological Promise and Clinical Uncertainty.},
author = {Mokbel K and Abugheida I and Venkataraman J and Al-Shamsi HO},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18182986},
url = {https://doi.org/10.3390/cancers18182986}
}RIS
TY - JOUR TI - Axillary De-Escalation After Neoadjuvant Therapy in cN2/N3 HER2-Positive and Triple-Negative Breast Cancer: Navigating Biological Promise and Clinical Uncertainty. AU - Mokbel K AU - Abugheida I AU - Venkataraman J AU - Al-Shamsi HO PY - 2026 JO - Cancers DO - 10.3390/cancers18182986 UR - https://doi.org/10.3390/cancers18182986 ER -
APA
K, M., I, A., J, V., & HO, A. (2026). Axillary De-Escalation After Neoadjuvant Therapy in cN2/N3 HER2-Positive and Triple-Negative Breast Cancer: Navigating Biological Promise and Clinical Uncertainty.. Cancers. https://doi.org/10.3390/cancers18182986
Source records
- pubmed · retrieved 2026-09-26T19:10:56.733Z